Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Treatment of Superficial Basal Cell Carcinoma by Topical Photodynamic Therapy With Fractionated 5-aminolevulinic Acid 20% Versus Two Stage Topical Photodynamic Therapy With Methylaminolevulinate

NCT01491711 is registered in ClinicalTrials.gov with Maastricht University Medical Center as lead sponsor.

NCT NCT01491711
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01491711 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Treatment of Superficial Basal Cell Carcinoma by Topical Photodynamic Therapy With Fractionated 5-aminolevulinic Acid 20% Versus Two Stage Topical Photodynamic Therapy With Methylaminolevulinate
Lead sponsor
Maastricht University Medical Center
Phase
Phase 4
Overall status
Unknown status
Start date
August 31, 2013
Completion date
April 30, 2015
Enrollment
162 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

superficial basal cell carcinoma